OUR TEAM

34 Years of Combined Industry Investment and Operating Experience

Andrew Cohan

FOUNDER & PARTNER

read bio

Andrew Cohan is Founder and Partner of Halmos Capital.

Previously, Andrew worked at Perry Capital, a multi-strategy, multi-billion dollar hedge fund headquartered in New York City. While at Perry, Andrew was a member of a six-person illiquid special situations investment team where he focused on a variety of private investments across industries.

Prior to working on illiquid investments, Andrew held primary responsibility for investing in healthcare products companies on Perry’s long/short equities team including biotechnology, pharmaceuticals, specialty pharmaceuticals, medical technology and equipment. Specifically, he engaged in strategies including long/short equities, merger arbitrage, credit and private equity.

Before joining Perry, Andrew was a member of the biotechnology team in the equity research division at Goldman Sachs & Co. At Goldman, he worked for an Institutional Investor #2 ranked biotechnology team.

Prior to Goldman, Andrew worked in the healthcare investment banking group at Merrill Lynch. He executed a variety of transactions while at Merrill Lynch, including mergers & acquisitions, debt/equity financings and IPOs.

Andrew earned a Bachelor of Science in Biochemistry from the University of Virginia, where he was an Echols Scholar and graduated Phi Beta Kappa.

Daniel Adan

PARTNER

read bio

Daniel Adan is a Partner with Halmos Capital.

Prior to Halmos, Dan was Director of Research in the Fundamental Strategies group at Magnetar Capital, a $14 billion hedge fund, where he focused his time investing across the capital structure in a variety of sectors.

Before joining Magnetar, Dan was a portfolio manager and Managing Director at Perry Capital, a $10 billion hedge fund, where he executed over $2 billion in investments across a variety of asset classes and strategies.

Dan began his career within the Investment Banking Division at Goldman Sachs & Co., where he advised corporate management teams within the Industrials, Business Services and Energy sector.

Dan graduated summa cum laude from the Warrington College of Business at the University of Florida with a B.S. degree in Finance.

Dan sits on the Board of Trustees at KIPP NJ and KIPP Miami, a Charter School Management Organization, where he chairs the Finance Committee.

Eric Alimena

SENIOR ASSOCIATE

read bio
Eric Alimena is a Senior Associate at Halmos Capital.

Prior to Halmos, Eric was an Associate at Aterian Investment Partners, a $2 billion middle market private equity firm, where he focused on the due diligence and underwriting of new platform and add-on investments across a variety of industries along with general portfolio management activities.

Before Aterian, Eric was an Investment Banking Analyst at Ducera Partners where he focused on a broad range of advisory assignments, including Mergers & Acquisitions, Restructuring, and Special Situations. Eric began his career in the Global Industrials Investment Banking Group at Morgan Stanley.

Eric graduated cum laude from Johns Hopkins University with a B.A. in Economics and a minor in Accounting & Financial Management. He was also a sprinter and a captain of the Varsity Men’s Track and Field team.

Our Advisors

Our advisors consist of former CEOs, senior management, current and former board members of leading public and private companies in their respective sectors and successful entrepreneurs.

Andrew Cohan

FOUNDER & PARTNER

read bio

Andrew Cohan is Founder and Partner of Halmos Capital.

Previously, Andrew worked at Perry Capital, a multi-strategy, multi-billion dollar hedge fund headquartered in New York City. While at Perry, Andrew was a member of a six-person illiquid special situations investment team where he focused on a variety of private investments across industries.

Prior to working on illiquid investments, Andrew held primary responsibility for investing in healthcare products companies on Perry’s long/short equities team including biotechnology, pharmaceuticals, specialty pharmaceuticals, medical technology and equipment. Specifically, he engaged in strategies including long/short equities, merger arbitrage, credit and private equity.

Before joining Perry, Andrew was a member of the biotechnology team in the equity research division at Goldman Sachs & Co. At Goldman, he worked for an Institutional Investor #2 ranked biotechnology team.

Prior to Goldman, Andrew worked in the healthcare investment banking group at Merrill Lynch. He executed a variety of transactions while at Merrill Lynch, including mergers & acquisitions, debt/equity financings and IPOs.

Andrew earned a Bachelor of Science in Biochemistry from the University of Virginia, where he was an Echols Scholar and graduated Phi Beta Kappa.

Daniel Adan

PARTNER

read bio

Daniel Adan is a Partner with Halmos Capital.

Prior to Halmos, Dan was Director of Research in the Fundamental Strategies group at Magnetar Capital, a $14 billion hedge fund, where he focused his time investing across the capital structure in a variety of sectors.

Before joining Magnetar, Dan was a portfolio manager and Managing Director at Perry Capital, a $10 billion hedge fund, where he executed over $2 billion in investments across a variety of asset classes and strategies.

Dan began his career within the Investment Banking Division at Goldman Sachs & Co., where he advised corporate management teams within the Industrials, Business Services and Energy sector.

Dan graduated Summa Cum Laude from the Warrington College of Business at the University of Florida with a B.S. degree in Finance.

Dan sits on the Board of Trustees at KIPP NJ and KIPP Miami, a Charter School Management Organization, where he chairs the Finance Committee.

Eric Alimena

SENIOR ASSOCIATE

read bio
Eric Alimena is a Senior Associate at Halmos Capital.

Prior to Halmos, Eric was an Associate at Aterian Investment Partners, a $2 billion middle market private equity firm, where he focused on the due diligence and underwriting of new platform and add-on investments across a variety of industries along with general portfolio management activities.

Before Aterian, Eric was an Investment Banking Analyst at Ducera Partners where he focused on a broad range of advisory assignments, including Mergers & Acquisitions, Restructuring, and Special Situations. Eric began his career in the Global Industrials Investment Banking Group at Morgan Stanley.

Eric graduated cum laude from Johns Hopkins University with a B.A. in Economics and a minor in Accounting & Financial Management. He was also a sprinter and a captain of the Varsity Men’s Track and Field team.

Our Advisors

Our advisors consist of former CEOs, senior management, current and former board members of leading public and private companies in their respective sectors and successful entrepreneurs.